Data protection Impressum

Technology Park

A new EY study ranks Switzerland 3rd worldwide for corporate R&D intensity and 6th for total spending, with 14 Swiss companies among the global top 500.

Business environment

Switzerland ranks 3rd globally for corporate R&D intensity

18 May 2026

French spare parts specialist FACTORYYY has chosen the Marly Innovation Center in Fribourg to launch its Swiss operations, targeting manufacturers in the energy, rail, and industrial sectors.

Why FACTORYYY chose the Marly Innovation Center to launch its Swiss operations

Lausanne-based AC Immune has amended its license and collaboration agreement with Eli Lilly to advance new Tau Morphomer small molecule candidates for Alzheimer's disease and other neurodegenerative diseases, with IND-enabling studies set to commence in the first half of 2026.

AC Immune secures CHF 10 million from Lilly to advance Alzheimer’s therapy

15 April 2026

miros, an EPFL ecosystem start-up developing a network of bookable connected workpods, has closed a CHF 1 million pre-seed round to scale its deployment across Switzerland, targeting over 100 units by end of 2026.

miros raises CHF 1 million to deploy a national network of connected workpods

31 March 2026

Switzerland has ranked first in the Henley Opportunity Index 2026, scoring 86 out of 100 across six structural drivers of long-term prosperity, further cementing its standing as the world's leading destination for talent, investment, and quality of life.

Switzerland tops the 2026 Henley Opportunity Index

30 March 2026

Harnessing the promise of emerging quantum technologies, Western Switzerland is shaping up to be a pivotal region in this transformative field.

Why Switzerland

Quantum technologies in Western Switzerland

The Swiss Data Science Center has officially inaugurated its new headquarters at Biopôle in Lausanne, marking its first independent home outside its founding institutions EPFL and ETH Zurich.

The Swiss Data Science Center inaugurates its headquarters at Biopôle in Lausanne

16 March 2026

Seprify has raised CHF 12.25 million in Series A funding to transition its cellulose platform from pilot validation into industrial-scale supply across cosmetics, food, and coatings markets.

Seprify raises CHF 12.25 million to scale its cellulose-based materials platform

11 March 2026

EPFL spin-off Verretex has secured CHF 1.2 million in dilutive and non-dilutive funding to expand its industrial production of recycled glass fiber textiles and accelerate its entry into new markets.

Verretex raises CHF 1.2 million to scale recycled glass fiber production

4 March 2026

As life sciences companies navigate increasingly complex global markets, the decision of where to establish or expand international operations has become a strategic one.

Why Life Sciences Companies Choose Switzerland to Scale Internationally

1 2 3 4 5 6 … 19